Sleep Disorders Market Growth: Increasing Demand for Advanced Diagnosis and Treatment Solutions
According to a new report by Polaris Market Research, the global sleep disorders market was valued at USD 25.03 billion in 2024 and is projected to reach USD 66.55 billion by 2034, expanding at a CAGR of 10.3% over the forecast period. Growth is underpinned by rising telemedicine adoption, expanding use of wearable sleep-monitoring devices, and accelerating demand for non-pharmacological treatment options across key end-use settings.
What Is Driving Sleep Disorders Market Growth?
Demand is climbing as the growing global prevalence of insomnia, sleep apnea, and related conditions converges with rising awareness of how sleep quality affects overall health. Healthcare providers and patients alike are prioritizing early diagnosis, pushing sleep disorders market adoption across home care, hospitals, and specialty sleep laboratories. Polaris analysts note that the integration of artificial intelligence into diagnostic and therapy devices positions the market for sustained double-digit growth through 2034, with hospitals and sleep laboratories emerging as the largest revenue contributor and home care settings posting the fastest incremental gains.
Key Trends Shaping the Sleep Disorders Industry
Increased Adoption of Telemedicine
Remote consultations and virtual monitoring have become mainstream for diagnosing and managing conditions such as insomnia and sleep apnea. Industry bodies have reported that telemedicine consultations for sleep-related issues grew sharply during and after the pandemic, a shift that continues to reduce barriers to specialist care and support overall market outlook.
Advancements in Wearable Sleep Monitoring Devices
Smartwatches and dedicated sleep trackers are increasingly used to monitor sleep stages, heart rate, and movement, giving users a more personalized view of sleep health. Roughly three in ten U.S. adults now use some form of wearable or mobile technology to track sleep, and continued improvements in sensor accuracy and AI-driven data interpretation are expected to boost early detection and market growth.
Growth of Non-Pharmacological Treatment Options
Cognitive behavioral therapy for insomnia (CBT-I) and related non-drug approaches are gaining traction as first-line treatments recommended by leading medical associations. Clinical research has linked CBT-I to significant improvement in sleep outcomes for the large majority of patients with chronic insomnia, reinforcing demand for non-pharmacological therapies and shaping the competitive landscape.
Market Segmentation: Breaking Down the Sleep Disorders Market
Polaris segments the sleep disorders market by disorder, product, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.
By Disorder
The insomnia segment led the market, reflecting its high prevalence — an estimated 30% of adults experience some form of insomnia — and its association with comorbidities such as anxiety and depression. The sleep apnea segment, particularly obstructive sleep apnea, is projected to register the strongest growth as diagnostic tools such as home sleep testing and CPAP therapy adoption expand.
Read More @ https://www.polarismarketresearch.com/industry-analysis/sleep-disorder-market
By Product
Diagnostics currently hold the larger revenue share, supported by tools such as polysomnography, actigraphy, and home sleep apnea tests, alongside rising wearable-device adoption. The therapeutics segment is expected to register a higher growth rate as CPAP therapy, CBT-I, and new drug formulations expand, signaling where near-term demand — and search intent around "sleep apnea treatment" — is shifting.
By End User
Hospitals and sleep laboratories captured the largest share in 2024, given their established diagnostic infrastructure and specialized treatment capabilities. Home care settings are expected to post the strongest incremental growth, reflecting patient preference for at-home diagnostics, wearable monitors, and telemedicine-enabled follow-up care.
Regional Outlook: Where Is the Sleep Disorders Market Growing Fastest?
North America led the market in 2024 on the back of a well-established healthcare system, high sleep-disorder diagnosis rates, and strong adoption of advanced diagnostic and therapeutic technologies, while Asia Pacific is expected to post a fast CAGR through 2034, driven by improving healthcare access and rising diagnosis rates in China, Japan, and India. Within North America, the US remains the largest single market; within Asia Pacific, China and India are the primary growth engines. Europe rounds out the top three, supported by government initiatives and rising adoption of home sleep testing and CBT-I.
Competitive Landscape: Leading Sleep Disorders Companies
Key players profiled in the report include ResMed, Philips Healthcare, Medtronic, and Fisher & Paykel Healthcare, who are focusing on product innovation, AI integration, and expanded home-care offerings to strengthen market position across the insomnia and diagnostics segments outlined above. Recent moves include ResMed's acquisition of an AI-based diagnostics specialist to strengthen its sleep apnea offerings and Philips' launch of a new line of smart, personalized sleep-therapy devices, both aimed at deepening share in North America and Europe.
Why It Matters for Buyers Evaluating Sleep Disorder Market Entry
For stakeholders researching the sleep disorders industry, this report benchmarks market share, segment-level pricing, and forecast data — by disorder, product, end user, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing diagnostic and therapeutic suppliers, investors sizing entry points, and strategy teams tracking home care as a growth adjacency.
More Trending Latest Reports By Polaris Market Research:
U.S. Medical Examination Lights Market
Titanium Dioxide (TiO2) Market
Nach Verein filtern
Read More
According to the latest report published by Data Bridge Market Research, the Middle East and Africa Botanical Extract Market CAGR Value Middle East and Africa Botanical Extract Market analysis report contains significant data, current market trends, market environment, technological innovation, upcoming technologies and the technical progress in the allied industry. All...
Loose dentures are a common problem experienced by many people who have lost multiple teeth. Although dentures can restore appearance and basic chewing ability, some patients struggle with movement, discomfort, or difficulty speaking because the dentures do not stay firmly in place. Modern dentistry offers an effective solution for improving denture stability through implant-supported...
If you've just finished Plus Two and are stuck between commerce and management, the two strongest integrated options right now are BCom + ACCA for a finance and accounting career, and BBA + American PGDM for management specializations like logistics or advanced business administration. Both combine a recognized Indian degree with globally aligned professional training over three years, so you...
Hybrid Vegetable Seeds are designed to help farmers grow healthy vegetables with higher yields and better quality. Developed through advanced breeding methods, Hybrid Vegetable Seeds combine the best traits of selected parent plants to produce vigorous growth, uniform vegetables, and consistent harvests. They are widely preferred by farmers looking for better productivity and long-term...
The global seafood extracts market is witnessing significant growth, driven by rising consumer demand for innovative food products, expanding applications across pharmaceuticals and cosmetics, and increasing awareness about the nutritional benefits of marine-derived ingredients. Valued at US$ 8 Bn in 2021, the market is projected to grow at a CAGR of 5.3% from 2022 to 2031,...
